NEW YORK, May 5 (GenomeWeb News) - Harvard Bioscience yesterday reported a 7.7-percent increase in first-quarter revenues, with organic revenue growth of 11.9 percent.
In PLOS this week: mutation in second gene widens clinical symptoms of people with ADD3 mutations, comparative genomic analysis of Pseudovibrio, and more.
